IP Verse

Betapharm Arzneimittel patent opposition analysis

Get complete Patent Opposition Report for Betapharm Arzneimittel

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Betapharm Arzneimittel

Explore patent oppositions filed by Betapharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3494972	Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection	VIIV HEALTHCARE	Sep 11, 2024
EP3626270	New Use	NOVARTIS	Jul 2, 2024
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 7, 2023
EP3461503	Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring	BIOMARIN PHARMACEUTICAL	Oct 28, 2022
EP2545939	Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring	BIOMARIN PHARMACEUTICAL	Sep 15, 2021
EP2340828	Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor	NOVARTIS	Apr 15, 2021
EP3395338	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Dec 9, 2020
EP3395339	Rapid Dissolution Formulation Of A Cinacalcet Hcl	AMGEN	Dec 9, 2020
EP3260117	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Nov 24, 2020
EP3038654	New Use	NOVARTIS	Jul 30, 2020

Top competitors of Betapharm Arzneimittel

NOVARTIS

AMGEN

AVENTIS PHARMA